Dr. Kelsey Moody, CEO at Ichor, speaks on a panel at the 2019 NIA Geroscience Summit

Ichor’s CEO Participates in NIA Geroscience Summit

Posted Leave a commentPosted in Auctus Biologics, Ichor

4 – 5 November 2019 Bethesda, MD: The third annual Geroscience Summit was organized by the Trans-NIH Geroscience Interest Group (GSIG). The Geroscience Summit is hosted by the National Institute of Health, and brings together interdisciplinary experts in the field of age-related diseases to bring their expertise to the field of geroscience. Geroscience seeks interdisciplinary […]

Dr. Danique Wortel presenting about Managing Methuselah mice

Ichor’s Attending Veterinarian Participates in AALAS’ 70th National Meeting

Posted Leave a commentPosted in Ichor

13 – 17 October 2019 Denver, CO: The American Association for Laboratory Animal Science‘s (AALAS) National Meeting is the largest meeting in the world dedicated to the care, production, and use of laboratory animals. This year Ichor was represented by Dr. Danique Wortel, DVM, attending veterinarian, and Dr. Forrest Wright, PhD, Operations Manager of Husbandry. […]

Dr. Kelsey Moody, CEO at Ichor speaking on panel at Leaf Conference

Ichor CEO Delivered Lysoclear Update and Held Workshop at Annual LEAF Conference

Posted Posted in Ichor, Lysoclear

12 July 2019  NEW YORK, NY: The second annual Life Extension Advocacy Foundation (LEAF) Ending Age Related Diseases Conference was held in New York City July 11-12th. This conference brought together many of the top minds in the biotechnology rejuvenation field, including Dr. Kelsey Moody, CEO at Ichor Therapeutics, Inc. Dr. Moody also held a workshop prior to the conference, on July 10th.   The workshop was held in the Cooper Union […]

J.P. Morgan running race

Ichor’s Jacob McAndrew takes 6th in JP Morgan Corporate Challenge

Posted Posted in Ichor

On May 21st, 2019 ten Ichor employees participated in the JP Morgan Corporate Challenge at Onondaga Lake Park. The Ichor team ran 3.5 miles (5.6km) alongside many other local companies in order to raise money for the non-profit organization, Syracuse Stage, while encouraging health and fitness in the workplace, camaraderie amongst employees, and promoting an overall environmentally friendly lifestyle. At this event, Jacob McAndrew, Operations Manager of Cell Biology at Ichor Therapeutics, Inc., placed 6th out of 5,000 participants, with a time of 19:01.

Scientist at Ichor in LaFayette, NY

Ichor’s Auctus Biologics Closes Quick $1.5MM

Posted Posted in Auctus Biologics, Ichor

Auctus Biologcs, Inc., a new portfolio company of Ichor Therapeutics, Inc., announced today the closure of $1.5MM in seed funding. The company will develop RPtag, a hyper-stable antibody mimetic scaffold published earlier this year in the peer-reviewed journal ACS Biochemistry, to take on conventional clinical antibody therapy as an orally bioavailable formulation. New high priority immunosenescence and gastrointestinal targets will also be pursued.

Ichor Portfolio Company, Antoxerene, Closes $10MM Deal with Juvenescence

Posted Posted in Antoxerene, FoxBio, Ichor

Antoxerene, Inc., a portfolio company of Ichor Therapeutics, Inc., focused on small molecule drug discovery for pathways of aging, announced today the launch of a joint venture with Juvenescence Limited. The joint venture, called FoxBio, Inc., will develop Antoxerene’s collection of small molecules that target senescent cells. Juvenescence will support the venture with $10 million in equity financing and drug development expertise.